HOLMDEL, N.J., June  10, 2026  (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that

BKYI

BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing

BKYI Faces Nasdaq Compliance Risk as Listing Review Looms

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>HOLMDEL, N.J., June  10, 2026  (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>BIO-key International (BKYI) disclosed Nasdaq notified it was not compliant with listing rules after failing to timely file its Q1 2026 Form 10-Q. The Nasdaq Hearing Panel will determine whether BKYI can maintain its Nasdaq Capital Market listing. The outcome may affect BKYI&#039;s liquidity and access to capital in the near term.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>BKYI receives Nasdaq notice for late Q1 2026 10-Q. Hearing Panel will decide listing.</li><li>Failure to file Q1 2026 Form 10-Q triggers Rule 5250(c)(1). Nasdaq to decide status.</li><li>BKYI&#039;s PortalGuard IAM serves 40M+ users. Business overview.</li><li>Hearing outcome may affect liquidity and listing status.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>BIO-key International, Inc. (BKYI)</strong>: Facing Nasdaq compliance issue; potential listing risk.</li><li><strong>Nasdaq, Inc. (NDAQ)</strong>: Operator of Nasdaq exchange; regulatory outcome could affect BKYI&#039;s listing status.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal. The article centers on regulatory compliance and potential listing consequences, a key governance and liquidity risk for BKYI.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Nasdaq non-compliance notice could trigger delisting actions or penalties.</li><li>Potential listing suspension may reduce BKYI liquidity.</li><li>Hearing outcome within weeks could spark volatility.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>BKYI trades on OTC Markets under BKYI.</li><li>Nasdaq notified BKYI of non-compliance with Listing Rule 5250(c)(1).</li><li>Non-compliance due to failure to timely file Form 10-Q for quarter ended Mar 31, 2026.</li><li>Nasdaq Hearing Panel will determine continued listing on Nasdaq Capital Market.</li><li>PortalGuard IAM serves 40M+ users.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term BKYI price risk until Nasdaq resolves listing status; watch for cure extension.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">HOLMDEL, N.J., June  10, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=EgOWmeqrA4pvoKqhfQTJQe3tLnjvBA7rIPWXawsyMrcTq8knYrJxBZYrbgmfonyMpXFFGT4vaEr10Ig-wp1NxLau8eWBwDITX1bBEEEN-CY=" rel="nofollow" target="_blank"><strong>BIO-key International, Inc.</strong></a> (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. In the notice, Nasdaq further informed the Company that the Nasdaq Hearing Panel will consider the forgoing in rendering a determination regarding the Company's continued listing on the Nasdaq Capital Market.</p>  <p align="justify"><strong>About BIO-key International, Inc. </strong>(<a href="https://www.globenewswire.com/Tracker?data=UJ2myG0NdT8FCYiPKMUoUb6yrPENdBt4qrsnDdDYahacJdAG9Kiqg2PLMH9MpWbXbqr9XRR5TAjtx3kEm3DvFPPIa8R9FCcwKydz10W1nu0=" rel="nofollow" target="_blank"><strong>www.BIO-key.com</strong></a><strong>)<br></br></strong>BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2" style="width:100%;"><strong>Engage with BIO-key:</strong></td></tr><tr><td style="width:29.5826%;;vertical-align: middle ; ">Facebook – Corporate:</td><td style="width:70.4174%;;vertical-align: middle ; "><a href="https://www.facebook.com/BIOkeyInternational/" rel="nofollow" target="_blank">https://www.facebook.com/BIOkeyInternational/</a></td></tr><tr><td style="width:29.5826%;;vertical-align: middle ; ">LinkedIn – Corporate:</td><td style="width:70.4174%;;vertical-align: middle ; "><a href="https://www.linkedin.com/company/bio-key-international" rel="nofollow" target="_blank">https://www.linkedin.com/company/bio-key-international</a></td></tr><tr><td style="width:29.5826%;;vertical-align: middle ; ">X – Corporate:</td><td style="width:70.4174%;;vertical-align: middle ; "><a href="https://x.com/BIOkeyIntl" rel="nofollow" target="_blank">@BIOkeyIntl</a></td></tr><tr><td style="width:29.5826%;;vertical-align: middle ; ">X – Investors:</td><td style="width:70.4174%;;vertical-align: middle ; "><a href="https://x.com/BIO_keyIR" rel="nofollow" target="_blank">@BIO_keyIR</a></td></tr><tr><td style="width:29.5826%;;vertical-align: middle ; ">StockTwits:</td><td style="width:70.4174%;;vertical-align: middle ; "><a href="https://stocktwits.com/BIO_keyIR" rel="nofollow" target="_blank">BIO_keyIR</a></td></tr><tr><td style="width:29.5826%;;vertical-align: middle ; "> </td><td style="width:70.4174%;;vertical-align: middle ; "> </td></tr></table> <p align="justify"><strong>Investor Contacts:</strong><br></br>William Jones, David Collins<br></br>Catalyst IR<br></br><a href="https://www.globenewswire.com/Tracker?data=NlOq17OP-qMebiIVDmAnxosXbmPTc0Hk1tPoeGNowCZYbFNbpIQNVQGgWYWywjRSJM5LYw55JOPJq41CQNQgxOT0bKe_vKrLuaDcsOAeKzVT82n1voT4HWLyhiCkYL_Y" rel="nofollow" target="_blank"><strong>BKYI@catalyst-ir.com</strong></a><br></br>212-924-9800</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTczNTIxMCM3NjU2NTM2IzIwODg0MTM="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/Y2FmODQzZTMtYjI3OS00ZDM4LTkzN2UtZjI3YjRhZDJmYTI4LTEwOTk5ODQtMjAyNi0wNi0xMC1lbg==/tiny/BIO-key-International-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/4bca27c0-f7ad-4c90-9fab-226813a884b3"><img src="https://ml.globenewswire.com/media/4bca27c0-f7ad-4c90-9fab-226813a884b3/small/yahoo-logo-1029x579-jpg.jpg" border="0" width="150" height="84" alt="Primary Logo"></img></a></p>

BIO-key International (BKYI) disclosed Nasdaq notified it was not compliant with listing rules after failing to timely file its Q1 2026 Form 10-Q. The Nasdaq Hearing Panel will determine whether BKYI can maintain its Nasdaq Capital Market listing. The outcome may affect BKYI's liquidity and access to capital in the near term.

BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News